Casgevy: UK approves gene-editing drug for blood disorders
Briefly

This is a revolutionary advance for two inherited blood conditions, both triggered by errors in the gene for haemoglobin.
DNA is the blueprint of life - and genes contain the instructions for how every cell in our body works.
Both sickle cell disease and beta thalassemia are painful, life-long conditions that currently require ongoing treatments.
Read at BBC News
[
add
]
[
|
|
]